<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">344928</id>
  <title nil="true"/>
  <common-name>5-methyl-8-(4-(111c)methylpiperazin-1-yl)-n-(4-morpholin-4-ylphenyl)-4-oxochromene-2-carboxamide</common-name>
  <description>5-methyl-8-(4-(111c)methylpiperazin-1-yl)-n-(4-morpholin-4-ylphenyl)-4-oxochromene-2-carboxamide is a compound with the formula C26H30N4O4. It has an average molecular weight of 461.50 g/mol.</description>
  <cas>947239-72-7</cas>
  <pubchem-id>42608431</pubchem-id>
  <chemical-formula>C26H30N4O4</chemical-formula>
  <weight>461.5</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T07:09:36Z</created-at>
  <updated-at type="dateTime">2026-08-31T07:09:36Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC1=C2C(=O)C=C(OC2=C(C=C1)N3CCN(CC3)C)C(=O)NC4=CC=C(C=C4)N5CCOCC5</moldb-smiles>
  <moldb-formula>C26H30N4O4</moldb-formula>
  <moldb-inchi>InChI=1S/C26H30N4O4/c1-18-3-8-21(30-11-9-28(2)10-12-30)25-24(18)22(31)17-23(34-25)26(32)27-19-4-6-20(7-5-19)29-13-15-33-16-14-29/h3-8,17H,9-16H2,1-2H3,(H,27,32)/i2-1</moldb-inchi>
  <moldb-inchikey>JKPWOPNZKYPRPZ-JVVVGQRLSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">461.238138</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>2.6</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM340821</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>5-methyl-8-(4-(111c)methylpiperazin-1-yl)-n-(4-morpholin-4-ylphenyl)-4-oxochromene-2-carboxamide</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Benzenoids</superklass>
  <klass>Benzene and substituted derivatives</klass>
  <subklass>Anilides</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0295291</sync-id>
  <structure-inchikey>JKPWOPNZKYPRPZ-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>20000004000000000000000000000040000000000000100010000014000000000001000000020000000000000000000000100000000000000000002000000001000000000000000000000000000000020800010010000000000000000000000000000010000000010000100100000000000220100020000000000800002000000400040000400000000000000004080000000000000000000080000000000000100000000000000000000080100040000000040000000008000000800000000000000008000000800000000000000000000100000002000000220000000000000008040000000000040000000001400000080000000308000000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>7014c4108d128650a1005b608138a2001a82140091052000003d204082a44a4e6c220050138000000100490840c0000004600225c08d32310966643d00a04010c7110c0012801c0110b01040037203000804858051a13f3340241d62402259040c28052f00480220c00c8481ddb4004c208680508101e1047198a44002718212104408184ef0820808060250c83c0018391d9812c4d41e8a5023082060c000a118d3111380b0c22002040968057c35104ac004128941884812a04a184cc80212a01000e4c4d900330180848454110ad00d410030034050000d61128028000300b05445160881010011400401711220822850053490c2040e11081c8052000606</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAiAAAAJgAAAIABBgBgAAAAAQMGQCgAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:44:07Z</structure-indexed-at>
</compound>
